|
AU2018280270A1
|
|
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US2019343771A1
|
|
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US2018161345A1
|
|
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
CN110290793A
|
|
Natural composition hormone replacement agent and treatment
|
|
US2018280410A1
|
|
Natural combination hormone replacement formulations and therapies
|
|
US2018221389A1
|
|
Natural combination hormone replacement formulations and therapies
|
|
CA3019375A1
|
|
Steroid hormone pharmaceutical composition
|
|
WO2017173044A1
|
|
Steroid hormone compositions in medium chain oils
|
|
KR20180126582A
|
|
Steroid hormone pharmaceutical composition
|
|
US2017281647A1
|
|
Steroid hormone compositions in medium chain oils
|
|
US2017216310A1
|
|
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
WO2017100378A2
|
|
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US2017056418A1
|
|
Formulations for solubilizing hormones
|
|
AU2015296609A1
|
|
Transdermal cream
|
|
AU2015264003A1
|
|
Natural combination hormone replacement formulations and therapies
|
|
US2015202211A1
|
|
Progesterone formulations having a desirable pk profile
|
|
CA2942568A1
|
|
Progesterone formulations
|
|
US2015196640A1
|
|
Progesterone formulations having a desirable pk profile
|
|
US2015045335A1
|
|
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
EP3060179A1
|
|
Vaginal inserted estradiol pharmaceutical compositons and methods
|
